Differential cardiac impacts of hematological malignancies and solid tumors: a histopathological and biomarker study
2024

Cardiac Effects of Blood Cancers vs Solid Tumors

Sample size: 362 publication 10 minutes Evidence: moderate

Author Information

Author(s): Udin Michael H., Sunder Sunitha Shyam, Nepali Sarmila, Kattel Sharma, Abdelradi Amr, Doyle Scott T., Ionita Ciprian N., Liu Qian, Sharma Umesh C.

Primary Institution: Roswell Park Comprehensive Cancer Center

Hypothesis

How do hematological malignancies affect cardiac morphology compared to solid tumors?

Conclusion

Hematological malignancy patients show more cardiac dysfunction and structural changes than those with solid tumors.

Supporting Evidence

  • Hematological malignancy patients had lower cardiomyocyte nuclei counts than solid tumor patients.
  • HM patients showed higher levels of B-type natriuretic peptide, indicating cardiac stress.
  • Collagen fiber alignment was significantly lower in HM patients compared to ST patients.

Takeaway

Patients with blood cancers have more heart problems than those with other types of cancer.

Methodology

The study analyzed cardiac changes in 198 patients with hematological malignancies and 164 patients with solid tumors, comparing demographics, echocardiogram data, and post-mortem findings.

Potential Biases

Treatment variability and lack of longitudinal data may confound results.

Limitations

The study's retrospective nature and reliance on post-mortem evaluations may introduce selection biases and affect data accuracy.

Participant Demographics

Average age was 60, with 134 females and 228 males; most common cancer was acute myeloid leukemia.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40959-024-00285-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication